GUTS Fractyl Health, Inc. - Common Stock
$0,82
Prix · Mai 20, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$0–$3
16% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$5
+539% upside
P/E (TTM)
-1.2
ROE
3220.3%
Marge nette
—
GUTS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.82
Capitalisation Boursière
$337M
P/E (TTM)
-1.2
BPA (TTM)
$-1.86
Revenus (TTM)
$0
Rendement div.
—
ROE
3220.3%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $3
GUTS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2023-12-31
→
2025-12-31
BPA
$-1.86
2023-12-31
→
2025-12-31
Flux de trésorerie libre
$-91M
2024-12-31
→
2025-12-31
Marges
—
2024-12-31
→
2024-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
GUTS
Médiane des pairs
P/E (TTM)
-1.2
15.7
P/B
35.7
3.4
Price / FCF (Cours / FCF)
-3.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
GUTS
Médiane des pairs
ROA
-122.8%
-25.4%
ROE
3220.3%
-39.7%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
GUTS
Médiane des pairs
Current Ratio (Ratio de liquidité)
4.8
4.6
Quick Ratio (Ratio de liquidité réduite)
4.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
GUTS
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-22.5%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
GUTS
Médiane des pairs
GUTS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 4 36,4%
- Achat 5 45,5%
- Conserver 2 18,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-05-19
Médiane
$6.20
Moyenne
$5.24
← En dessous de tous les objectifs
$0.82
Bas
$2.00
Haut
$8.00
Objectif médian
$6.20
+656,2%
Objectif moyen
$5.24
+539,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.13 | $-0.16 | 0.03% |
| 31 décembre 2025 | $-0.07 | $-0.18 | 0.11% |
| 30 septembre 2025 | $-0.71 | $-0.32 | -0.39% |
| 30 juin 2025 | $-0.57 | $-0.37 | -0.20% |
| 31 mars 2025 | $-0.49 | $-0.49 | -0.00% |
| 31 décembre 2024 | $-0.52 | $-0.44 | -0.08% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| GUTS | $337M | -1.2 | -22.5% | — | 3220.3% | — |
| OWLT | — | -5.5 | 35.4% | — | — | — |
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| APYX | $146M | -6.1 | 9.9% | -21.2% | -78.0% | 62.5% |
| HYPR | — | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| SNWV | $256M | 72.8 | 35.0% | 26.8% | -395.5% | 77.1% |
| HSDT | $126M | -1.6 | 1057.1% | -679.6% | -26.6% | 91.7% |
| MBOT | $134M | -6.9 | — | — | -24.4% | — |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | — |
| FONR | $92M | 10.1 | 1.4% | 8.0% | 4.9% | — |
| KEQU | $90M | 8.3 | 18.0% | 4.7% | 18.2% | 28.6% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $93.0K | $120.0K | |
| Cost of Revenue | $0 | $50.0K | $77.0K | |
| Gross Profit | · | $43.0K | $43.0K | |
| R&D Expense | $75M | $70M | $38M | |
| SG&A Expense | $22M | $23M | $13M | |
| Operating Expenses | $97M | $94M | $51M | |
| Operating Income | $-97M | $-94M | $-51M | |
| Interest Income | $2M | $4M | $1M | |
| Other Non-op | $-53.0K | $-47.0K | $-24.0K | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-141M | $-69M | $-77M | |
| EPS (Basic) | $-1.86 | $-1.62 | $-45.29 | |
| EPS (Diluted) | $-1.86 | $-1.62 | $-45.29 | |
| Shares (Basic) | 75,819,960 | 43,541,527 | 2,081,328 | |
| Shares (Diluted) | 75,819,960 | 43,541,527 | 2,081,328 | |
| EBITDA | $-97M | $-94M | · |
Bilan 20
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $82M | $67M | $33M | |
| Receivables | · | $0 | $22.0K | |
| Inventory | · | $73.0K | $73.0K | |
| Current Assets | $88M | $72M | $36M | |
| PP&E (Net) | $2M | $3M | $490.0K | |
| PP&E (Gross) | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $2M | $5M | |
| Other Non-current Assets | $337.0K | $666.0K | $6M | |
| Total Assets | $121M | $108M | $76M | |
| Accounts Payable | $2M | $3M | $553.0K | |
| Current Liabilities | $18M | $20M | $11M | |
| Capital Leases | $26M | $27M | $29M | |
| Other Non-current Liabilities | $663.0K | $998.0K | · | |
| Total Liabilities | $112M | $80M | $114M | |
| Common Stock | $1.0K | $0 | $0 | |
| Paid-in Capital | $566M | $444M | $22M | |
| Retained Earnings | $-556M | $-415M | $-347M | |
| Stockholders' Equity | $9M | $28M | $-325M | |
| Liabilities + Equity | $121M | $108M | $76M | |
| Shares Outstanding | 153,372,044 | 48,755,451 | 2,105,815 |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $7M | $14M | $4M | |
| Operating Cash Flow | $-90M | $-66M | $-43M | |
| CapEx | $557.0K | $2M | $359.0K | |
| Investing Cash Flow | $-557.0K | $-2M | $-359.0K | |
| Stock Issued | $7M | · | · | |
| Net Stock Activity | $7M | · | · | |
| Financing Cash Flow | $105M | $101M | $27M | |
| Net Change in Cash | $14M | $34M | $-16M | |
| Free Cash Flow | $-91M | $-67M | · |
Rentabilité 6
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | · | 46.2% | · | |
| Operating Margin | · | -100571.0% | · | |
| Net Margin | · | -73864.5% | · | |
| EBITDA Margin | · | -100571.0% | · | |
| ROA | -122.8% | -74.6% | · | |
| ROE | 3220.3% | -174.5% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 4.8 | 3.6 | · | |
| Quick Ratio | 4.4 | 3.4 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Inventory Turnover | · | 0.7 | · | |
| Receivables Turnover | · | 8.5 | · |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -22.5% | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $93.0K | $120.0K | |
| Net Income TTM | $-141M | $-69M | $-77M | |
| Market Cap | $337M | $100M | · | |
| P/E | -1.2 | -1.3 | · | |
| P/S | · | 1080.0 | · | |
| P/B | 35.7 | 3.5 | · | |
| P / Tangible Book | 35.7 | 3.5 | · | |
| P / Cash Flow | -3.7 | -1.5 | · | |
| P / FCF | -3.7 | -1.5 | · | |
| Earnings Yield | -84.5% | -78.6% | · |
Compte de résultat 15
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $3.0K | $14.0K | $43.0K | $33.0K | $7.0K | $36.0K | $72.0K | $5.0K | |
| Cost of Revenue | · | · | · | · | · | $0 | $7.0K | $24.0K | $19.0K | $2.0K | $25.0K | $47.0K | $3.0K | |
| Gross Profit | · | · | · | · | · | $3.0K | $7.0K | $19.0K | $14.0K | $5.0K | $11.0K | $25.0K | $2.0K | |
| R&D Expense | $16M | $16M | $17M | $21M | $19M | $20M | $19M | $17M | $14M | $10M | $9M | $9M | $9M | |
| SG&A Expense | $5M | $7M | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $3M | $5M | $3M | $3M | |
| Operating Expenses | $21M | $23M | $23M | $26M | $25M | $25M | $24M | $23M | $22M | $13M | $14M | $12M | $12M | |
| Operating Income | $-21M | $-23M | $-23M | $-26M | $-25M | $-25M | $-24M | $-23M | $-22M | $-13M | $-14M | $-12M | $-12M | |
| Interest Income | $593.0K | $645.0K | $166.0K | $226.0K | $503.0K | $726.0K | $947.0K | $1M | $1M | $463.0K | $226.0K | $154.0K | $417.0K | |
| Other Non-op | · | $-11.0K | $-6.0K | $-15.0K | $-21.0K | $-10.0K | $-9.0K | $-18.0K | $-10.0K | $-8.0K | $-8.0K | $-17.0K | $9.0K | |
| Net Income | $9M | $-44M | $-46M | $-28M | $-24M | $-25M | $-23M | $-17M | $-3M | $-19M | $-16M | $-30M | $-12M | |
| EPS (Basic) | $0.06 | $-0.09 | $-0.71 | $-0.57 | $-0.49 | $-0.61 | $-0.48 | $-0.36 | $-0.17 | $-11.19 | $-9.61 | $-16.62 | $-7.87 | |
| EPS (Diluted) | $0.06 | $-0.09 | $-0.71 | $-0.57 | $-0.49 | $-0.61 | $-0.48 | $-0.36 | $-0.17 | $-11.19 | $-9.61 | $-16.62 | $-7.87 | |
| Shares (Basic) | 158,492,158 | -86,741,387 | 64,652,953 | 49,042,926 | 48,865,468 | -82,068,684 | 47,973,951 | 47,899,349 | 29,736,911 | -4,140,962 | 2,089,932 | 2,076,959 | 2,055,399 | |
| Shares (Diluted) | 158,492,158 | -86,741,387 | 64,652,953 | 49,042,926 | 48,865,468 | -82,068,684 | 47,973,951 | 47,899,349 | 29,736,911 | -4,140,962 | 2,089,932 | 2,076,959 | 2,055,399 | |
| EBITDA | $-21M | · | $-23M | $-26M | $-25M | · | $-24M | $-23M | $-22M | · | · | · | · |
Bilan 20
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $82M | $78M | $22M | $42M | $67M | $85M | $102M | $121M | $33M | · | · | · | |
| Receivables | · | · | · | · | · | · | $0 | $22.0K | $15.0K | $22.0K | · | · | · | |
| Inventory | · | · | · | · | · | $73.0K | $73.0K | $64.0K | $73.0K | $73.0K | · | · | · | |
| Current Assets | $66M | $88M | $80M | $27M | $47M | $72M | $88M | $107M | $124M | $36M | · | · | · | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $490.0K | · | · | · | |
| PP&E (Gross) | · | $5M | · | · | · | $5M | · | · | · | $5M | · | · | · | |
| Accum. Depreciation | · | $3M | · | · | · | $2M | · | · | · | $5M | · | · | · | |
| Other Non-current Assets | $681.0K | $337.0K | $392.0K | $458.0K | $571.0K | $666.0K | $3M | $3M | $3M | $6M | · | · | · | |
| Total Assets | $99M | $121M | $114M | $62M | $83M | $108M | $127M | $146M | $164M | $76M | · | · | · | |
| Accounts Payable | $2M | $2M | $1M | $4M | $1M | $3M | $2M | $2M | $1M | $553.0K | · | · | · | |
| Current Liabilities | $15M | $18M | $19M | $22M | $19M | $20M | $16M | $14M | $13M | $11M | · | · | · | |
| Capital Leases | $26M | $26M | $26M | $27M | $27M | $27M | $28M | $28M | $28M | $29M | · | · | · | |
| Other Non-current Liabilities | $569.0K | $663.0K | $753.0K | $838.0K | $920.0K | $998.0K | $1M | $964.0K | $330.0K | · | · | · | · | |
| Total Liabilities | $78M | $112M | $117M | $80M | $77M | $80M | $77M | $76M | $79M | $114M | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Paid-in Capital | $568M | $566M | $509M | $449M | $445M | $444M | $441M | $438M | $434M | $22M | · | · | · | |
| Retained Earnings | $-547M | $-556M | $-513M | $-467M | $-439M | $-415M | $-390M | $-367M | $-350M | $-347M | · | · | · | |
| Stockholders' Equity | $21M | $9M | $-3M | $-18M | $6M | $28M | $50M | $71M | $84M | $-325M | · | · | · | |
| Liabilities + Equity | $99M | $121M | $114M | $62M | $83M | $108M | $127M | $146M | $164M | $76M | · | · | · | |
| Shares Outstanding | 158,648,963 | 153,372,044 | 132,216,275 | 49,917,791 | 48,920,221 | 48,755,451 | 48,089,625 | 47,913,235 | 47,896,908 | 2,105,815 | · | · | · |
Flux de trésorerie 9
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $1M | $3M | $3M | $4M | $5M | $1M | $1M | $1M | $857.0K | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-21M | $-25M | $-17M | $-18M | $-19M | $-12M | $-11M | $-11M | $-12M | $-10M | |
| CapEx | · | $3.0K | $8.0K | $98.0K | $448.0K | $233.0K | $213.0K | $260.0K | $1M | $136.0K | $148.0K | $55.0K | $20.0K | |
| Investing Cash Flow | · | $-3.0K | $-8.0K | $-98.0K | $-448.0K | $-233.0K | $-213.0K | $-260.0K | $-1M | $-136.0K | $-148.0K | $-55.0K | $-20.0K | |
| Stock Issued | $170.0K | $5M | $477.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $170.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $25M | $78M | $1M | $171.0K | $67.0K | $162.0K | $-5.0K | $101M | $-556.0K | $28M | $28.0K | $-2.0K | |
| Net Change in Cash | $-18M | $4M | $55M | $-20M | $-25M | $-17M | $-18M | $-19M | $88M | $-11M | $17M | $-12M | $-10M | |
| Free Cash Flow | · | · | · | · | $-26M | · | · | · | $-13M | · | · | · | · |
Rentabilité 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 50.0% | 44.2% | 42.4% | · | · | · | · | |
| Operating Margin | · | · | · | · | · | · | -169957.1% | -53453.5% | -65278.8% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | -165521.4% | -40067.4% | -10066.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | -169957.1% | -53453.5% | -65278.8% | · | · | · | · | |
| ROA | 10.1% | · | -37.8% | -26.8% | -19.2% | · | -36.5% | -23.5% | -4.1% | · | · | · | · | |
| ROE | 66.4% | · | -193.5% | -106.2% | -52.4% | · | -92.1% | -48.7% | -7.9% | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | · | 4.3 | 1.2 | 2.5 | · | 5.6 | 7.5 | 9.4 | · | · | · | · | |
| Quick Ratio | 4.1 | · | 4.2 | 1.0 | 2.2 | · | 5.4 | 7.2 | 9.2 | · | · | · | · |
Efficacité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | · | · | · | · | · | · | 0.2 | 0.8 | 0.5 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 3.9 | 4.4 | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $126.0K | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $184.0K | $146.0K | · | · | · | · | |
| Net Income TTM | $-88M | · | $-120M | $-92M | $-67M | · | $-59M | $-67M | $-61M | · | · | · | · | |
| Market Cap | $73M | · | $210M | $81M | $58M | · | $122M | $205M | $354M | · | · | · | · | |
| P/E | -0.3 | · | -0.7 | -0.9 | -0.8 | · | -0.2 | -0.2 | -0.2 | · | · | · | · | |
| P/S | 576.7 | · | 1668.4 | 641.8 | 462.0 | · | 965.6 | 1111.9 | 2427.7 | · | · | · | · | |
| P/B | 3.4 | · | -66.1 | -4.4 | 9.1 | · | 2.4 | 2.9 | 4.2 | · | · | · | · | |
| P / Tangible Book | 3.4 | · | · | · | 9.1 | · | 2.4 | 2.9 | 4.2 | · | · | · | · | |
| P / Cash Flow | -3.2 | · | · | · | -2.3 | · | · | · | -30.3 | · | · | · | · | |
| P / FCF | · | · | · | · | -2.3 | · | · | · | -27.8 | · | · | · | · | |
| Earnings Yield | -373.4% | · | -141.5% | -117.3% | -126.0% | · | -419.8% | -626.7% | -463.1% | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenu | $0 | $93.0K | $120.0K |
| Marge Brute % | — | 46.2% | — |
| Marge d'exploitation % | — | -100571.0% | — |
| Résultat net | $-141M | $-69M | $-77M |
| BPA dilué | $-1.86 | $-1.62 | $-45.29 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio de liquidité | 4.8 | 3.6 | — |
| Ratio de liquidité réduite | 4.4 | 3.4 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flux de trésorerie libre | $-91M | $-67M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.